Literature DB >> 22450545

The condensed MCMDM-1 VWD bleeding questionnaire as a predictor of bleeding disorders in women with unexplained menorrhagia.

Hanan A G Azzam1, Hayam R Goneim, Amr M El-Saddik, Emad Azmy, Mohammed Hassan, Solafa El-Sharawy.   

Abstract

Menorrhagia is a common clinical problem and is unexplained in more than 50% of women. Many studies have suggested that underlying bleeding disorders are prevalent in menorrhagic women. However, the assessment and quantifying of hemorrhagic symptoms are still limited and not widely used. Thirty women aged 11-31 years with a clinical diagnosis of unexplained menorrhagia were investigated to assess the diagnostic utility of the condensed MCMDM-1VWD bleeding questionnaire as a predictive of bleeding disorders in these women. In addition to administration of the questionnaire, comprehensive hemostatic testing was performed to all women. The incidence of inherited bleeding disorders among this group was 66.6% (20/30). Eight patients had von Willebrand disease (VWD) and seven had possible Glanzmann's thrombasthenia. Rare bleeding disorders including hemophilia A carrier, Afibrinogenemia, Factor V deficiency and combined factor V and factor VIII deficiency were also identified. The receiver operator characteristic analysis of the condensed MCMDM-1 VWD bleeding questionnaire in menorrhagic women showed that the cutoff, sensitivity, specificity, positive and negative predictive values were 3.5, 85, 90, 89 and 86%, respectively. Bleeding score was strongly correlated to bleeding time in women with possible Glanzmann's thrombasthenia. In VWD, a significant inverse correlation between the bleeding score and the VW factor levels was detected with a significant increase of bleeding score in type III VWD compared with type I. Bleeding disorders are common in women with unexplained menorrhagia and the condensed MCMDM-1VWD bleeding questionnaire can distinguish between menorrhagic women with and without bleeding disorders and help assess their severity.

Entities:  

Mesh:

Year:  2012        PMID: 22450545     DOI: 10.1097/MBC.0b013e32835274d9

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

Review 1.  Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency.

Authors:  P James; O Salomon; D Mikovic; F Peyvandi
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

2.  A 24-year-old woman with heavy menstrual bleeding.

Authors:  Michelle Sholzberg; Jerome Teitel; Lisa K Hicks
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

Review 3.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

4.  A cross-sectional study of bleeding phenotype in haemophilia A carriers.

Authors:  Allison Paroskie; Dave Gailani; Michael R DeBaun; Robert F Sidonio
Journal:  Br J Haematol       Date:  2015-04-01       Impact factor: 6.998

5.  Use of electronic self-administered bleeding assessment tool in diagnosis of paediatric bleeding disorders.

Authors:  Dominder Kaur; Bryce A Kerlin; Joseph R Stanek; Sarah H O'Brien
Journal:  Haemophilia       Date:  2021-06-05       Impact factor: 4.263

6.  Coagulation test understanding and ordering by medical trainees: Novel teaching approach.

Authors:  Nadia Gabarin; Martina Trinkaus; Rita Selby; Nicola Goldberg; Hina Hanif; Michelle Sholzberg
Journal:  Res Pract Thromb Haemost       Date:  2022-06-17

7.  Screening platelet function in blood donors.

Authors:  Pascal Pedini; Jean-Baptiste Baudey; Katia Pouymayou; Celine Falaise; Manal Ibrahim-Kosta; Melanie Vélier; Clémence Demerle; Hajer Graiet; Catherine Dragutini; Anne-Marie Dombey; Jacques Chiaroni; Marie Christine Alessi; Christophe Picard
Journal:  Transfusion       Date:  2022-06-24       Impact factor: 3.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.